Single-dose Pharmacokinetics of Pociredir in Participants With Sickle Cell Disease

Summary

This clinical trial is a study to evaluate the pharmacokinetics of the tablet formulation Pociredir in fasted and fed state participants with Sickle Cell Disease (SCD).

Timeline

Start

2025-12-13

Primary completion

2026-06-01

Completion

2026-06-01

Outcome

Outcome not reported

Stopped (Business): “Sponsor decision”

Drugs

Indications